Portal about medicine, treatment of disease.

Neupro(R), The Only Transdermal Patch For Restless Legs Syndrome, Now Available In The UK

The only transdermal patch in the UK for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome (RLS) in adults was launched by UCB. Applied once-a-day, Neupro® (rotigotine transdermal patch) allows for continuous drug delivery to provide stable drug levels in the bloodstream 24 hours a day and improves symptom control day and night.
drugs without prescription

A New UK Survey Suggests Primary Care Clinicians Need Clearer Post-Mi Guidelines To Provide Their Patients With Optimal Care

A new survey published in the British Journal of Cardiology suggests that inconsistencies in clinical guidance for the ongoing management of post-myocardial infarction (MI) patients may contribute to significant variation in clinical practice reported by GPs and practice nurses.1a These findings indicate that, in some areas of the UK, care for post-MI patients after leaving hospital may not be optimal,1b according to authors from the Follow Your Heart group. *

News of the day

MAP Pharmaceuticals Phase 3 Trial Of Levadex™ Migraine Product Candidate Meets All Four Primary Endpoints

MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced that the efficacy portion of its first Phase 3 clinical trial evaluating its novel LEVADEX™ orally inhaled migraine therapy met all four primary endpoints. Additional endpoints showed that LEVADEX provided rapid and sustained pain relief for up to 48 hours after dosing.